The land area of Lower Allen, PA was 2 in 2011. The land area of West View, PA was 1 in 2011.
Land Area
Water Area
Land area is a measurement providing the size, in square miles, of the land portions of geographic entities for which the Census Bureau tabulates and disseminates data. Area is calculated from the specific boundary recorded for each entity in the Census Bureau's geographic database. Land area is based on current information in the TIGER® data base, calculated for use with Census 2010.
Water Area figures include inland, coastal, Great Lakes, and territorial sea water. Inland water consists of any lake, reservoir, pond, or similar body of water that is recorded in the Census Bureau's geographic database. It also includes any river, creek, canal, stream, or similar feature that is recorded in that database as a two- dimensional feature (rather than as a single line). The portions of the oceans and related large embayments (such as Chesapeake Bay and Puget Sound), the Gulf of Mexico, and the Caribbean Sea that belong to the United States and its territories are classified as coastal and territorial waters; the Great Lakes are treated as a separate water entity. Rivers and bays that empty into these bodies of water are treated as inland water from the point beyond which they are narrower than 1 nautical mile across. Identification of land and inland, coastal, territorial, and Great Lakes waters is for data presentation purposes only and does not necessarily reflect their legal definitions.
Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API -
Geographic and Area Datasets Involving West View, PA or Lower Allen, PA
- API
Safe Drinking Water Facilities Information System for Pennsylvania 2018 - Current Environmental Protection
data.pa.gov | Last Updated 2022-10-24T13:20:24.000ZSafe Drinking Water Information System (SDWIS) is EPA’s national database that manages and collects public water system information from states, including reports of drinking water standard violations, reporting and monitoring violations, and other basic information. The data derived in the State of Pennsylvania is published and searchable online on the www.pa.gov website. This set contains the Water System Facility data, which will be updated annually for the prior calendar year in the first Quarter of the following year.
- API
PA Turnpike Service Plazas Current Statewide Transportation
data.pa.gov | Last Updated 2022-08-16T14:31:33.000ZLocation of the Service Plazas or Rest Areas that have different services available besides only restrooms along the Pennsylvania Turnpikes Routes 76 and 476. Going East, West and Both Directions.
- API
Dispensation Data without Buprenorphine Quarter 3 2016 - Current Quarterly County Health
data.pa.gov | Last Updated 2024-08-12T15:42:38.000ZView quarterly trends in opioid dispensation data for all Schedule II-V opioids. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx More information from U.S. Department of Justice https://www.deadiversion.usdoj.gov/schedules/ Schedule I Controlled Substances Substances in this schedule have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. Some examples of substances listed in Schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine ("Ecstasy"). Schedule II/IIN Controlled Substances (2/2N) Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence. Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone (Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl (Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine, and hydrocodone. Examples of Schedule IIN stimulants include: amphetamine (Dexedrine®, Adderall®), methamphetamine (Desoxyn®), and methylphenidate (Ritalin®). Other Schedule II substances include: amobarbital, glutethimide, and pentobarbital. Schedule III/IIIN Controlled Substances (3/3N) Substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. Examples of Schedule III narcotics include: products containing not more than 90 milligrams of codeine per dosage unit (Tylenol with Codeine®), and buprenorphine (Suboxone®). Examples of Schedule IIIN non-narcotics include: benzphetamine (Didrex®), phendimetrazine, ketamine, and anabolic steroids such as Depo®-Testosterone. Schedule IV Controlled Substances Substances in this schedule have a low potential for abuse relative to substances in Schedule III. Examples of Schedule IV substances include: alprazolam (Xanax®), carisoprodol (Soma®), clonazepam (Klonopin®), clorazepate (Tranxene®), diazepam (Valium®), lorazepam (Ativan®), midazolam (Versed®), temazepam (Restoril®), and triazolam (Halcion®). Schedule V Controlled Substances Substances in this schedule have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics. Examples of Schedule V substances include: cough preparations containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams (Robitussin AC®, Phenergan with Codeine®), and ezogabine.
- API
Estimated Drug Overdose Deaths CY 2012-Current County Health
data.pa.gov | Last Updated 2024-08-12T15:47:24.000ZPrior dataset name - Estimated Accidental and Undetermined Drug Overdose Deaths CY 2012-Current County Health <br> View annual counts of Any Drug overdose deaths for 2012 forward, including provisional estimates of annual counts of overdose deaths for recent years, as noted with an asterisk and the month the data was pulled. NOTE: Finalized death records for overdose deaths are often delayed by 3-6 months. Counties labeled “no value” have data suppressed because the counts are between 1 and 9. Counts do not include suicides or homicides where someone intended to harm another person by poisoning.<br> Overdose Deaths are classified using the International Classification of Diseases, Tenth Revision (ICD–10). Drug-poisoning deaths are identified using underlying cause-of-death codes X40–X44, and Y10–Y14, and include the following:<br> - R99 when the Injury Description indicates an overdose death. <br> - X49 when literal COD is Mixed or Combined or Multiple Substance Toxicity, as these are likely drug overdoses <br> - X47 when substance indicated is difluoroethane, alone or in combination with other drugs<br> - X85 when it does not appear that someone intended to harm another person by poisoning <br> Source Office of Drug Surveillance and Misuse Prevention* <br> * These data were supplied by the Bureau of Health Statistics and Registries, Harrisburg, Pennsylvania. The Bureau of Health Statistics and Registries specifically disclaims responsibility for any analyses, interpretations or conclusions.<br> Any Drug Overdose Death - all drug overdose deaths, regardless of type of drug involved, excluding alcohol only deaths
- API
Buprenorphine Dispensation Data Quarter 3 2016 - Current Quarterly Statewide Health
data.pa.gov | Last Updated 2024-08-12T15:42:31.000ZView quarterly trends in buprenorphine dispensation data. Please note that buprenorphine data received by the PDMP is restricted to prescriptions filled by pharmacies. The PDMP does not collect information on the reason a controlled substance is prescribed, nor does it collect data from substance abuse treatment facilities or dispensing prescribers providing buprenorphine for substance abuse treatment. Buprenorphine is sometimes prescribed off-label for pain. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx
- API
Estimated Accidental and Undetermined Drug Overdose Deaths with Demographics CY 2012-Current Statewide Health
data.pa.gov | Last Updated 2024-08-12T15:49:43.000ZView annual counts of Accidental or Undetermined overdose deaths for 2012 forward, including provisional estimates of annual counts of overdose deaths for recent years, as noted with an asterisk and the month the data was pulled.<br> NOTE: Finalized death records for overdose deaths are often delayed by 3-6 months. Counties labeled “no value” have data suppressed because the counts are between 1 and 9.<br> - Overdose Deaths are classified using the International Classification of Diseases, Tenth Revision (ICD–10). Drug-poisoning deaths are identified using underlying cause-of-death codes X40–X44, and Y10–Y14, and include the following: <br> - R99 when the Injury Description indicates an overdose death.<br> - X49 when literal COD is Mixed or Combined or Multiple Substance Toxicity, as these are likely drug overdoses<br> - X47 when substance indicated is difluoroethane, alone or in combination with other drugs<BR> - Source Pennsylvania Prescription Drug Monitoring Program*<br> * These data were supplied by the Bureau of Health Statistics and Registries, Harrisburg, Pennsylvania. The Bureau of Health Statistics and Registries specifically disclaims responsibility for any analyses, interpretations or conclusions.<br> - Estimates are broken down by type of drugs involved in the overdose <br> - Any Drug Overdose Death - all drug overdose deaths, regardless of type of drug involved, excluding alcohol only deaths<br> - Opioid Overdose Death - any overdose death involving opioids, prescription or illegal
- API
Emergency Department (ED) Visits for Drug Overdose Identified Through Syndromic Surveillance SFY Quarter 3 2016 - Current Quarterly County Health
data.pa.gov | Last Updated 2024-08-12T15:39:34.000ZBased on Emergency Department (ED) Visits view quarterly trends in overdose rates for Any Drug Overdoses, Any Opioid Overdoses and Heroin Overdoses at the state and county level. Please see Overdose Data Technical Notes for additional details: http://www.health.pa.gov/Your-Department-of-Health/Offices%20and%20Bureaus/PaPrescriptionDrugMonitoringProgram/Documents/OverdoseDataTechnicalNotes.pdf Syndromic surveillance is the analysis of medical data to detect or anticipate disease outbreaks. According to a CDC definition, "the term 'syndromic surveillance' applies to surveillance using health-related data that precede diagnosis and signal a sufficient probability of a case or an outbreak to warrant further public health response.
- API
Risky Prescribing Measures Quarter 3 2016 - Current Quarterly County & Statewide Health
data.pa.gov | Last Updated 2024-08-12T15:42:37.000ZView quarterly trends in Risky Prescribing Measures, including: o Number/Rate of Individuals Seeing 5+ Prescribers and 5+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals Seeing 4+ Prescribers and 4+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals Seeing 3+ Prescribers and 3+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals with an Average Daily MME >50, >90 or >120: Average Daily MME is calculated as the sum of the total MME on each day in a time period based on all prescriptions an individual has filled divided by the number of days in the prescription(s). Measures include the number and rate of individuals prescribed greater than 50 MME per day, greater than 90 MME per day, or greater than 120 MME per day and is based on the patient’s county of residence. o Number/Rate of Individuals with Overlapping Opioid/Benzodiazepine Prescriptions: Number of individuals receiving overlapping opioid and benzodiazepine prescriptions during a given quarter. This measure is based on the patients’ county of residence. o Number/Rate of Individuals with > 30 Days of Overlapping Opioid/Benzodiazepine Prescriptions: Number and rate of individuals receiving overlapping opioid and benzodiazepine prescriptions for 30 days or more during a given quarter using state/county populations as denominators. This measure is based on the patients’ county of residence. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx
- API
Occupational Wages 2018 Labor and Industry
data.pa.gov | Last Updated 2022-10-17T19:57:18.000ZRepresents a comprehensive collection of occupational wage data available for Pennsylvania. Data are collected through the Occupational Employment Statistics program in cooperation with the U.S. Department of Labor’s Bureau of Labor Statistics. Occupational wage information can be used as a reference by educators, PACareerLink® staff, career counselors, Workforce Development Boards, economic developers, program planners, and others. Technical Note Occupational wages do not represent a time series. Due to the prescribed production methodology, current occupational wages are not comparable to previously published occupational wages.
- API
Federated Water Quality Monitoring Station Data January 1998 - Current Annual County Environmental Protection
data.pa.gov | Last Updated 2021-07-16T19:37:08.000ZPA Department of Environmental Protection (DEP) Water Quality Network Station Location and Samples Data submitted to the Environmental Protection Agency (EPA) through the National Environmental Information Exchange Network for the national STORET data warehouse. Includes Monitoring Station location data and sample results from 2008 through June, 2017.